ASB20123

Send Inquiry
ASB20123
Details
Development code: ASB20123
Sequence: Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys-Val-Gln-Gln-Arg-Lys-Asp-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg (cyclized via Cys6-Cys22 disulfide bridge)
We also provide specifications from crude to 99% purity, please contact us for details!

Related documents
COA/MS/HPLC Report
Peptide Dissolution and Storage Guide
Category
Metabolic Regulatory Peptide / CNP Chimeric Long-acting Peptide
Category
Pharmaceutical Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of asb20123 in China, also supports custom service. Welcome to wholesale bulk high quality asb20123 from our factory. Contact us for more details.

 

Product name ASB20123
Description ASB20123 is a chimeric peptide of C-type natriuretic peptide (CNP) and ghrelin. It retains NPR-B receptor agonistic activity, and the C-terminal basic amino acid cluster prolongs half-life and enhances growth plate enrichment, potently promotes endochondral ossification, and is applied in mechanism research of achondroplasia, growth disorders and dwarfism.
Peptide purity (HPLC, %) 95%/98%/99%
Theoretical molecular weight ~4.2 kDa (with disulfide bridge)
Structure type CNP(1-22)-ghrelin(12-28, E17D) chimeric peptide

 

Product Basic Information Table

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Full Amino Acid Sequence Molecular Formula Exact Mass (Da) Average MW (Da) N-terminal Modification C-terminal Modification Sequence Length (aa)
ASB20123 ASB20123; CNP/ghrelin chimeric peptide; Long-acting bone growth peptide NPR-B receptor agonist,Promotes endochondral ossification,Growth disorder study,Achondroplasia research,Long half-life,Growth plate targeted enrichment Glycine-leucine-serine-lysine-glycine-cysteine-phenylalanine-glycine-leucine-lysine-leucine-aspartic acid-arginine-isoleucine-glycine-serine-methionine-serine-glycine-leucine-glycine-cysteine-valine-glutamine-glutamine-arginine-lysine-aspartic acid-serine-lysine-lysine-proline-proline-alanine-lysine-leucine-glutamine-proline-arginine (cyclized via Cys6-Cys22 disulfide bridge) Large peptide, no precise small-molecule formula; subject to actual batch MS - ~4200 (theoretical) Free amine Free carboxyl 39

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Conditions Short-term Storage Conditions Liquid Stability Solid Powder Stability
PEP-ASB001 White to off-white lyophilized powder Store at -20℃, strictly protected from light, sealed and dry, aliquoted. **Strictly prohibited from strong reducing agents** Solid powder stable for 2 years at 2-8℃ sealed and dry; prepare aqueous solutions freshly before use Stable for 72 h at 4℃; stable for 1 month at -20℃ in aliquots. **Good water solubility, freely soluble in water and acidic buffer**. Disulfide bridge is sensitive to reducing agents and prone to cleavage. Easily degraded under alkaline conditions Stable for 3 years at -20℃ under dry & dark conditions

 

Functional Description

 

Product Code Frontend Short Summary (for search list display) Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-ASB001 CNP/ghrelin chimeric long-acting peptide that targets growth plate to promote bone growth, applied in achondroplasia research ASB20123 is a chimeric peptide optimized for bone growth. The N-terminus retains the complete human CNP(1-22) active domain, which specifically activates natriuretic peptide receptor B (NPR-B), triggers the cGMP signaling pathway, promotes chondrocyte proliferation and differentiation, and accelerates endochondral ossification. The C-terminus is fused with an engineered ghrelin(12-28) fragment, which enhances binding to the growth plate extracellular matrix through the BX7B motif and basic amino acid cluster, prolongs local retention time and increases plasma half-life. Compared with native CNP, it has stronger bone targeting, longer in vivo half-life and significantly enhanced bone growth activity with no obvious cardiovascular side effects, serving as a core tool molecule for mechanism research of achondroplasia, dwarfism, bone growth disorders and long-acting bone growth drug development. Achondroplasia research,Growth disorder mechanism study,Bone development research,Long-acting peptide drug development,Natriuretic peptide pathway study,Dwarfism research Natriuretic Peptide Receptor B (NPR-B); cGMP signaling pathway; Chondrocyte proliferation and endochondral ossification pathway

Hot Tags: asb20123, China asb20123 manufacturers, suppliers, factory, 129954-34-3, 2381089-83-2, CAS 121062 08 6, CAS 1415456 99 3, CAS 2381089 83 2, Selank

Send Inquiry